CemiplimAb Survivorship Epidemiology

Clinical trial NCT03836105 · COMPLETED

Trial details

NCT number: NCT03836105
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Cutaneous Squamous Cell Carcinoma Basal Cell Carcinoma

Start date: 2019-06-27
Primary completion: 2025-09-29
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.